Saturday, December 26, 2020 9:11:55 PM
It was the reason why I took a stake in AMBS is 2012, however MANF is an untapped protein.
While it achieved ODD, it was targeted for 1st in-man clinical studies in 2016 under Catalent Pharma who was hired to perform cGMP for clinical-grade production of MANF, but no progress was ever made.
Its been around for decades, but has yet to make it out of preclinicals:
https://www.researchgate.net/project/Discovery-of-MANF
It sits in pre-clinicals 'proof of concept' for RP, RAO, AMD, DB, PK and MYO-CDI.
If it truly holds the possibility of being a genuine game changer, then why hasn't Gerald advanced it forward given unlimited time and opportunities to do so?
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM